Search - tctmd.com

Displaying 1 - 20 of 135

Sort: Relevancy | Date

News Conference News ACC 2026

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

Caitlin E. Cox

March 30, 2026

News Conference News CRT 2026

TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide

L.A. McKeown

March 19, 2026

News Daily News

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

Michael O'Riordan

February 19, 2026

News Daily News

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

L.A. McKeown

October 09, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2025

Michael O'Riordan

September 30, 2025

News Daily News

Early TAVI Valve Deterioration More Likely in Younger Patients, Smaller Annuli

Yael L. Maxwell

September 04, 2025

News Conference News NY Valves 2025

Solid, Early Surgical Results With Polymer Mitral Valve

Todd Neale

July 02, 2025

News Conference News EuroPCR 2025

Higher Mortality With TAVI Over Surgery in Bicuspid Aortic Stenosis

Michael O'Riordan

May 22, 2025

News Conference News HVS 2025

Solid Durability Seen With Surgical Resilia Tissue Aortic Valve

Yael L. Maxwell

April 21, 2025

News Daily News

COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year

Todd Neale

April 11, 2025

News Daily News

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

L.A. McKeown

February 24, 2025

News Conference News PCR London Valves 2024

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

Michael O'Riordan

November 27, 2024

News Conference News PCR London Valves 2024

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

Michael O'Riordan

November 26, 2024

Presentation TCT 2024

TCT 825: Hemodynamic Valve Deterioration in Under- vs Over-Expanded Balloon Expandable Transcatheter Aortic Valves

Presenter: Tyler Andrews

October 29, 2024

Presentation TCT 2024

TCT 955: Pathology of Non-calcific Structural Valve Deterioration in Transcatheter and Surgical Aortic Bioprosthesis

Presenter: Yu Sato

October 28, 2024

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

Presentation TCT 2024

TCT 205: Automatic Characterization of Post-TAVR CT for the Evaluation of Valve Deterioration

Presenter: Pablo Juan-Salvadores

October 27, 2024

News Daily News

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Caitlin E. Cox

June 21, 2024

News Conference News NY Valves 2024

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

Todd Neale

June 14, 2024

News Conference News EuroPCR 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Shelley Wood

May 15, 2024

Advertisement

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

TCTMD’s Top 10 Most Popular Stories for September 2025

Early TAVI Valve Deterioration More Likely in Younger Patients, Smaller Annuli

Solid, Early Surgical Results With Polymer Mitral Valve

Higher Mortality With TAVI Over Surgery in Bicuspid Aortic Stenosis

Solid Durability Seen With Surgical Resilia Tissue Aortic Valve

COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

TCT 825: Hemodynamic Valve Deterioration in Under- vs Over-Expanded Balloon Expandable Transcatheter Aortic Valves

TCT 955: Pathology of Non-calcific Structural Valve Deterioration in Transcatheter and Surgical Aortic Bioprosthesis

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

TCT 205: Automatic Characterization of Post-TAVR CT for the Evaluation of Valve Deterioration

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content